Production & Manufacturing
Today in Production & Manufacturing

Production & Manufacturing

Takeda agrees to acquire Shire for £45.3bn Takeda Pharmaceutical has agreed to acquire Ireland-based rare disease biotech company Shire in a cash-cum stock deal worth around £45.3bn. Production & Manufacturing > Manufacturing > News

Latest Production & Manufacturing News by Sector

Select a sector from the list or browse by sector below:

Fine & Speciality Chemicals

Bayer plans to focus entirely on Life Science businesses
Bayer intends in the future to focus entirely on the Life Science businesses – HealthCare and CropScience – and float MaterialScience on the stock market as a separate company. In this way Bayer is positioning itself as a world-leading company in the field of human, animal and plant health.
Production & Manufacturing > Fine & Speciality Chemicals > News
CordenPharma agrees to purchase Peptisyntha from Solvay
By PBR Staff Writer
International Chemical Investors Group (ICIG) and the Solvay Group have embarked on an agreement, whereby ICIG will purchase Belgium-based Peptisyntha SA, a custom manufacturer of peptides for pharmaceutical use.
Production & Manufacturing > Fine & Speciality Chemicals > News

Process & Production

Alexion seeks approval from FDA for PNH drug ALXN1210
Alexion Pharmaceuticals said that it has submitted a biologics license application (BLA) to the US Food and Drug Administration (FDA), seeking approval for its C5 complement inhibitor ALXN1210 for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH).
Production & Manufacturing > Process & Production > News
Celltrion resubmits aBLA to FDA for proposed Trastuzumab biosimilar
South Korea-based Celltrion said that it has completed a re-submission to the US Food and Drug Administration (FDA) seeking approval for CT-P6, a proposed mAb biosimilar to cancer drug Herceptin (trastuzumab).
Production & Manufacturing > Process & Production > News


Reckitt Benckiser drops plans to buy Pfizer's consumer healthcare business
By PBR Staff Writer
Reckitt Benckiser (RB) has dropped plans to acquire Pfizer's consumer healthcare business, which is made up of several over-the-counter (OTC) products sold in more than 90 countries.
Production & Manufacturing > OTC > News
Valeant to divest iNova Pharmaceuticals for $930m
By PBR Staff Writer
Valeant Pharmaceuticals International has agreed to divest its iNova Pharmaceuticals business for around $930m.
Production & Manufacturing > OTC > News


Novacap to acquire US-based CDMO PCI Synthesis
Novacap has agreed to acquire Boston-based PCI Synthesis, a pharmaceutical contract development and manufacturing organization (CDMO), for an undisclosed price.
Drug Research > Drug Delivery > News
Beactica signs three-year extension of master services deal with Sanofi
Swedish drug discovery company Beactica has entered into a three-year extension of its master services agreement with Sanofi.
Production & Manufacturing > Manufacturing > News